Entering text into the input field will update the search result below

Mayo Clinic study boosts Geron

Dec. 06, 2013 8:25 AM ETGeron Corporation (GERN) StockGERNBy: Colin Lokey, SA News Editor1 Comment
  • Shares of Geron (NASDAQ:GERN) are up 9% in premarket trading.
  • Behind the move looks to be an article outlining a Mayo Clinic study which says imetelstat "has been found to induce morphologic, molecular, and clinical remissions in some patients with myelofibrosis."
  • The study's lead author calls the results "early but promising."
  • Amusingly, the article appears to have been posted ahead of its scheduled release from embargo.
  • Full article is here

Recommended For You

About GERN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GERN--
Geron Corporation